Global Inhaled Nitric Oxide Market Report and Forecast 2023-2031: Inhaled Nitric Oxide Gaining Traction in Neonatal Care for Treatment of PPHN
08 août 2023 09h28 HE
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Global Inhaled Nitric Oxide Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global inhaled...
Global Inhaled Nitric Oxide Market (2022 to 2027) - Featuring Bellerophon Therapeutics, Beyond Air, BOC and Geno Among Others
22 juil. 2022 05h28 HE
|
Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "Global Inhaled Nitric Oxide Market (2022-2027) by Type, Applications, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis"...
[2020-2027] Inhaled Nitric Oxide Market to Garner $1.18 Billion, At CAGR of 8.1%: AMR
17 févr. 2021 09h30 HE
|
Allied Market Research
Portland, OR, Feb. 17, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Inhaled Nitric Oxide Market was pegged at $634.4 million in 2019, and is anticipated...
Patent Issuance Allowed for Single-Use or Short-Term Nitric Oxide Delivery Device
28 mai 2020 08h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, May 28, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide delivery in the...
Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19
25 mars 2020 06h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, March 25, 2020 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device company which investigates and develops applications and devices for nitric oxide in the medical...
Nu-Med Plus Accelerates FDA Submission in Light of Patent Ruling
10 sept. 2019 08h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA...
Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
05 févr. 2019 05h30 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology will receive its first clinical unit...
Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry
04 déc. 2018 08h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, released an open letter from Nu-Med Plus...
Nu-Med Plus, Inc. Announces Strategic Rebrand to Focus on Leading Advancements in the Nitric Oxide Delivery Industry
09 oct. 2018 07h30 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces a new articulation of the...
Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study
11 sept. 2018 07h00 HE
|
Nu-Med Plus Inc.
SALT LAKE CITY, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB: NUMD), a medical device leader developing new nitric oxide delivery technology, announces that Dr. Ronald Day, a...